abstract |
The invention relates to a sulfonyl hydrazide compound and its use as medicine for treating hepatitis B. Specifically, the present invention discloses a compound having a structure represented by chemical formula A, or its stereoisomer or tautomer, or its pharmaceutically acceptable salt, hydrate or solvent, which can be used as an HBV inhibitor Compounds, the definition of each group is detailed in the instructions. The present invention also relates to a pharmaceutical composition comprising the above compound and its use in treating hepatitis B. |